From the Journals

Firearm-related deaths show recent increase


 

FROM HEALTH AFFAIRS

After years of relative stability, firearm-related mortality in the United States rose sharply starting in 2015, according to analysis of a national mortality database.

Changes in firearm mortality rates from 1999 to 2017

U.S. firearm mortality was 10.4 per 100,000 person-years during 1999-2014, with the high in that period occurring in 2012 and dropping each of the next 2 years – compared with 11.8 per 100,000 during 2015-2017, an increase of 13.8%, Jason E. Goldstick, PhD, and associates wrote Oct. 8 in Health Affairs.

The majority of the 612,310 firearm deaths over the entire study period were suicides, with the proportion rising slightly from 58.6% in 1999-2014 to 60.0% in 2015-2017. Homicides made up 38.5% of deaths in 1999-2014 and 37.9% in 2015-2017, while the combined share of unintentional and undetermined deaths dropped from 2.9% to 2.1%, the investigators reported.

“What we can see is a worsening epidemic of firearm mortality that is geographically and demographically broad,” Dr. Goldstick of the University of Michigan, Ann Arbor, said in a separate written statement.

The geographic broadness can be seen when the change in mortality from 1999-2014 to 2015-2017 was calculated for each locale: 29 states had an increase of more than 20% and only 3 states (California, New York, and Rhode Island) and the District of Columbia had a decrease of at least 12.5%, they said. The data came from the Centers for Disease Control and Prevention’s Wide-ranging Online Data for Epidemiologic Research tool.

The different trends among states and subpopulations make it difficult to offer policy-based interventions. “The epidemiology of firearm violence is complex and varies based on the mechanism of death, demographic group under study, and regionally specific culture, making a one-size-fits-all solution inappropriate,” Dr. Goldstick and associates wrote.

The study was funded mainly by a grant from the National Institute of Child Health and Human Development. The investigators did not provide any information on conflicts of interest.

SOURCE: Goldstick JE et al. Health Aff. 2019;38(10):1646-52.

Recommended Reading

Unipolar vs bipolar depression: A clinician’s perspective
Journal of Clinical Outcomes Management
Hazardous cannabis use in MS linked to anxiety, depression
Journal of Clinical Outcomes Management
Ask patients about worst example of suicidal ideation
Journal of Clinical Outcomes Management
Suicide rates rise in U.S. adolescents and young adults
Journal of Clinical Outcomes Management
Anticholinergic drugs linked to dementia in older populations
Journal of Clinical Outcomes Management
Nothing to sneeze at: Upper respiratory infections and mood disorders
Journal of Clinical Outcomes Management
Mindfulness-based relapse prevention tied to lower anxiety, depression
Journal of Clinical Outcomes Management
Antidepressants for pediatric patients
Journal of Clinical Outcomes Management
Oral drug for postpartum depression aces phase 3 trial
Journal of Clinical Outcomes Management
Statins may do double duty as antidepressants
Journal of Clinical Outcomes Management